To Investigate the Clinical Efficacy and Potential Mechanism of Tongxinluo Capsules in Preventing Coronary Restenosis Based on Meta-Analysis and Network Pharmacology Analysis

Table 1

Baseline characterization of included literature.

Included studies and year	Treatment	Simple data		Group method of data handling (GMDH)	Age		Male		Intervening measure		Blind method
		T	C		T	C	T	C	T	C
Qi et al. 2012 [7]	6 M	32	28	Sequential order	Unclear	Unclear	Unclear	Unclear	①	②	Unclear
Lu et al. 2014 [8]	12 M	90	90	Random number table	60.2 ± 6.9	61.8 ± 7.2	53.30%	51.10%	①	②	Unclear
Tang et al. 2015 [9]	4 W	77	73	Random number table	53 ± 11	52 ± 10	59.70%	58.90%	①	②	Unclear
Wang et al. 2010 [10]	12 M	68	64	Random number table	65.2 ± 9.9	65.1 ± 10.4	63.20%	70.30%	①	②	Double blind
Liang et al. 2010 [11]	6 M	42	38	Random number table	Unclear	Unclear	Unclear	Unclear	①	②	Unclear
Deng et al. 2013 [12]	6 M	31	30	Random number table	59	59.5	67.70%	66.70%	①	②	Unclear
Yao et al. 2006 [13]	6 M	38	38	Random number table	56.6 ± 10.9	50.1 ± 12.4	Unclear	Unclear	①	②	Unclear
Feng et al. 2017 [14]	6 M	58	58	Random number table	61.02 ± 6.31	61.16 ± 6.34	67.2 0%	68.90%	①	②	Unclear
Zhang et al. 2018 [15]	6 M	60	60	Random number table	61.3 ± 5.5	62.4 ± 6.4	55.00%	Unclear	①	②	Unclear
Yang et al. 2016 [16]	6 M	172	171	Random number table	57.93 ± 9.77	58.63 ± 10.27	79.60%	78.30%	①	②	Double blind

T: experimental group, C: control group, ①: ACS secondary preventive treatment + Tongxinluo capsule, ②: ACS secondary preventive treatment.